Protective effect of metformin on diabetes mellitus, diabetic kidney disease and hepatocytes

Saeideh Darabi, Amin Hasanvand

Abstract


Diabetes mellitus is a series of metabolic disturbances followed by high blood glucose levels associated with insulin defciency. Critical long-time diffculties due to high blood glucose are nerve and kidney disorders, expansion of heart attack or stroke, serious vision impairment, and lesions of limbs. Suitable medicines used to treat diabetes include insulin and some oral medicines. Insulin injection is used to remedy type 1 diabetes and metformin as an available drug by mouth is used to remedy type 2 diabetes. Metformin can decrease the prevalence of type 2 diabetes mellitus by 31% after 3 years consumption and by 18% after 10 years consumption in people at risk for this disease. According to many studies, mechanisms of diabetic kidney disease are started by high production
of reactive oxygen species (ROS) and apoptosis. For keeping safe renal tubular cells and podocytes, physicians recommended administration of medications that stop renin-angiotensin–aldosterone system such as angiotensin converting enzyme (ACE) inhibitor or medications that block the effect of angiotensin II. Among the problems of diabetes mellitus, you can refer to multiple diseases of the liver including sediment of glycogen, nonalcoholic steatohepatitis (NASH), fbrosis and cirrhosis, biliary disease, cholelithiasis, cholecystitis, and complications of therapy of diabetes. The results of taking metformin have proven the protective effects of this drug against heart failure, liver problems, and kidney disease.

 

Citation: Darabi S, Hasanvand A. Protective effect of metformin on diabetes
mellitus, diabetic kidney disease and hepatocytes. Ann Res Antioxid. 2018;3(1):e03.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.



ISSN: 2476-5511



Publish Free - Access Free

 

A Publication of Society of Diabetic Nephropathy Prevention

 

Annals of Research in Antioxidants follows

 

http://publicationethics.org/resources/flowcharts

Publisher

This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 by Annals of Research in Antioxidants (ARA)\

Society of Diabetic Nephropathy Prevention